RAPS recognizes that the current situation in Ukraine impacts our members and customers on many levels. If you are directly impacted by the current situation in the region and are challenged to meet your deadlines or obligations to RAPS, please reach out to raps@raps.org so that we can defer those challenges. Your health and safety are paramount to us.

Regulatory Focus™ > News Articles > Quality & Compliance: Regulatory Forces Shaping Biopharmaceutical QA/QC in 2010

Quality & Compliance: Regulatory Forces Shaping Biopharmaceutical QA/QC in 2010

Posted 01 June 2010

Over the last 10 years, I have presented my impressions of the impact of changing regulatory forces on biopharmaceutical quality assurance/quality control (QA/QC) in the 21st century.1,2 Today, changing regulatory forces at both the US Food and Drug Administration (FDA) and the European Medicines Agency (EMA) continue to shape biopharmaceutical QA/QC in the following three ways:

 

© 2022 Regulatory Affairs Professionals Society.